FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2341823820> ?p ?o ?g. }

• W2341823820 endingPage "530" @default.
• W2341823820 startingPage "523" @default.
• W2341823820 abstract "Biological mediators have been used to enhance periodontal regeneration. The aim of this prospective randomized controlled study was to evaluate the safety and effectiveness of 3 doses of fibroblast growth factor 2 (FGF-2) when combined with a β-tricalcium phosphate (β-TCP) scaffold carrier placed in vertical infrabony periodontal defects in adult patients. In this double-blinded, dose-verification, externally monitored clinical study, 88 patients who required surgical intervention to treat a qualifying infrabony periodontal defect were randomized to 1 of 4 treatment groups—β-TCP alone (control) and 0.1% recombinant human FGF-2 (rh-FGF-2), 0.3% rh-FGF-2, and 0.4% rh-FGF-2 with β-TCP—following scaling and root planing of the tooth prior to a surgical appointment. Flap surgery was performed with EDTA conditioning of the root prior to device implantation. There were no statistically significant differences in patient demographics and baseline characteristics among the 4 treatment groups. When a composite outcome of gain in clinical attachment of 1.5 mm was used with a linear bone growth of 2.5 mm, a dose response pattern detected a plateau in the 0.3% and 0.4% rh-FGF-2/β-TCP groups with significant improvements over control and 0.1% rh-FGF-2/β-TCP groups. The success rate at 6 mo was 71% in the 2 higher-concentration groups, as compared with 45% in the control and lowest treatment groups. Percentage bone fill in the 2 higher-concentration groups was 75% and 71%, compared with 63% and 61% in the control and lowest treatment group. No increases in specific antibody to rh-FGF-2 were detected, and no serious adverse events related to the products were reported. The results from this multicenter trial demonstrated that the treatment of infrabony vertical periodontal defects can be enhanced with the addition of rh-FGF-2/β-TCP ( ClinicalTrials.gov NCT01728844)." @default.
• W2341823820 created "2016-06-24" @default.
• W2341823820 creator A5011727163 @default.
• W2341823820 creator A5019676251 @default.
• W2341823820 creator A5026235283 @default.
• W2341823820 creator A5034001337 @default.
• W2341823820 creator A5041529482 @default.
• W2341823820 creator A5044774272 @default.
• W2341823820 creator A5049080051 @default.
• W2341823820 creator A5049223816 @default.
• W2341823820 creator A5054510527 @default.
• W2341823820 creator A5059781203 @default.
• W2341823820 creator A5067805095 @default.
• W2341823820 creator A5067880985 @default.
• W2341823820 creator A5074682872 @default.
• W2341823820 creator A5087730723 @default.
• W2341823820 creator A5088771426 @default.
• W2341823820 date "2016-02-23" @default.
• W2341823820 modified "2023-10-17" @default.
• W2341823820 title "A Randomized Clinical Trial Evaluating rh-FGF-2/β-TCP in Periodontal Defects" @default.
• W2341823820 cites W1568141334 @default.
• W2341823820 cites W1942877698 @default.
• W2341823820 cites W1949832432 @default.
• W2341823820 cites W1969179287 @default.
• W2341823820 cites W1982777318 @default.
• W2341823820 cites W1991116656 @default.
• W2341823820 cites W1993763059 @default.
• W2341823820 cites W2009025335 @default.
• W2341823820 cites W2021208781 @default.
• W2341823820 cites W2037905867 @default.
• W2341823820 cites W2042027035 @default.
• W2341823820 cites W2050359727 @default.
• W2341823820 cites W2057391047 @default.
• W2341823820 cites W2057745100 @default.
• W2341823820 cites W2064720560 @default.
• W2341823820 cites W2071436259 @default.
• W2341823820 cites W2081257201 @default.
• W2341823820 cites W2085752169 @default.
• W2341823820 cites W2107704025 @default.
• W2341823820 cites W2109888379 @default.
• W2341823820 cites W2119102689 @default.
• W2341823820 cites W2124754142 @default.
• W2341823820 cites W2153389583 @default.
• W2341823820 cites W2156288673 @default.
• W2341823820 cites W2161512797 @default.
• W2341823820 doi "https://doi.org/10.1177/0022034516632497" @default.
• W2341823820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26908630" @default.
• W2341823820 hasPublicationYear "2016" @default.
• W2341823820 type Work @default.
• W2341823820 sameAs 2341823820 @default.
• W2341823820 citedByCount "63" @default.
• W2341823820 countsByYear W23418238202016 @default.
• W2341823820 countsByYear W23418238202017 @default.
• W2341823820 countsByYear W23418238202018 @default.
• W2341823820 countsByYear W23418238202019 @default.
• W2341823820 countsByYear W23418238202020 @default.
• W2341823820 countsByYear W23418238202021 @default.
• W2341823820 countsByYear W23418238202022 @default.
• W2341823820 countsByYear W23418238202023 @default.
• W2341823820 crossrefType "journal-article" @default.
• W2341823820 hasAuthorship W2341823820A5011727163 @default.
• W2341823820 hasAuthorship W2341823820A5019676251 @default.
• W2341823820 hasAuthorship W2341823820A5026235283 @default.
• W2341823820 hasAuthorship W2341823820A5034001337 @default.
• W2341823820 hasAuthorship W2341823820A5041529482 @default.
• W2341823820 hasAuthorship W2341823820A5044774272 @default.
• W2341823820 hasAuthorship W2341823820A5049080051 @default.
• W2341823820 hasAuthorship W2341823820A5049223816 @default.
• W2341823820 hasAuthorship W2341823820A5054510527 @default.
• W2341823820 hasAuthorship W2341823820A5059781203 @default.
• W2341823820 hasAuthorship W2341823820A5067805095 @default.
• W2341823820 hasAuthorship W2341823820A5067880985 @default.
• W2341823820 hasAuthorship W2341823820A5074682872 @default.
• W2341823820 hasAuthorship W2341823820A5087730723 @default.
• W2341823820 hasAuthorship W2341823820A5088771426 @default.
• W2341823820 hasConcept C126322002 @default.
• W2341823820 hasConcept C168563851 @default.
• W2341823820 hasConcept C170493617 @default.
• W2341823820 hasConcept C199343813 @default.
• W2341823820 hasConcept C2779337755 @default.
• W2341823820 hasConcept C2779416262 @default.
• W2341823820 hasConcept C2780385504 @default.
• W2341823820 hasConcept C71924100 @default.
• W2341823820 hasConcept C74373430 @default.
• W2341823820 hasConceptScore W2341823820C126322002 @default.
• W2341823820 hasConceptScore W2341823820C168563851 @default.
• W2341823820 hasConceptScore W2341823820C170493617 @default.
• W2341823820 hasConceptScore W2341823820C199343813 @default.
• W2341823820 hasConceptScore W2341823820C2779337755 @default.
• W2341823820 hasConceptScore W2341823820C2779416262 @default.
• W2341823820 hasConceptScore W2341823820C2780385504 @default.
• W2341823820 hasConceptScore W2341823820C71924100 @default.
• W2341823820 hasConceptScore W2341823820C74373430 @default.
• W2341823820 hasIssue "5" @default.
• W2341823820 hasLocation W23418238201 @default.
• W2341823820 hasLocation W23418238202 @default.
• W2341823820 hasOpenAccess W2341823820 @default.
• W2341823820 hasPrimaryLocation W23418238201 @default.

• next